Integrating Machine Learning and Epigenetic Biomarkers to Evaluate Dental Pulp Stem Cell-Based Therapies for Periodontal Tissue Regeneration

Authors

  • Joline Lof Department of Computer Science, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Iain Whittaker Department of Electrical Engineering and Computer Science, University of Missouri, Columbia, MO, USA.
  • Mirthe van Emmelen School of Electrical Engineering and Computer Science, Oregon State University, Corvallis, OR, USA.

Keywords:

periodontal regeneration, dental pulp stem cells, epigenetics, machine learning, biomarker discovery, federated learning, governance, translational medicine, fairness, regenerative dentistry

Abstract

Periodontal tissue regeneration remains a difficult translational problem because the periodontium is a composite, mechanically active, microbially exposed, and immunologically dynamic system. Dental pulp stem cells have emerged as a promising cell source for periodontal repair, yet their therapeutic behavior is shaped by donor heterogeneity, epigenetic state, senescence, immune modulation, and local niche conditions. This paper develops a system-level framework for integrating machine learning with epigenetic biomarkers to evaluate dental pulp stem cell-based therapies for periodontal tissue regeneration. The framework treats epigenetic markers as latent state variables that help explain why apparently similar cell preparations produce divergent regenerative outcomes. Machine learning is positioned not merely as a predictive instrument but as an infrastructural layer that connects multimodal data, including methylation and histone-related signatures, transcriptomic profiles, imaging, clinical periodontal measures, and manufacturing metadata. The discussion emphasizes architectural trade-offs among centralized learning, federated learning, interpretable modeling, and multimodal representation learning. It also examines deployment concerns such as data standardization, consent, model drift, validation, equity, environmental sustainability, and regulatory oversight. Particular attention is given to robustness and fairness because epigenetic and clinical datasets are often small, imbalanced, and shaped by ancestry, age, inflammation, and socioeconomic context. The paper argues that successful translation will depend less on isolated algorithmic performance and more on governance, interoperability, prospective validation, and adaptive policy. A conclusion outlines a translational agenda in which machine learning and epigenetic biomarkers jointly support safer, more reproducible, and more equitable dental pulp stem cell therapies for periodontal regeneration.

References

1. LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436–444. https://doi.org/10.1038/nature14539

2. Rajkomar, A., Dean, J., & Kohane, I. (2019). Machine learning in medicine. New England Journal of Medicine, 380(14), 1347–1358. https://doi.org/10.1056/NEJMra1814259

3. Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7

4. Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447–453. https://doi.org/10.1126/science.aax2342

5. Char, D. S., Shah, N. H., & Magnus, D. (2018). Implementing machine learning in health care—Addressing ethical challenges. New England Journal of Medicine, 378(11), 981–983. https://doi.org/10.1056/NEJMp1714229

6. Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proceedings of the National Academy of Sciences, 97(25), 13625–13630. https://doi.org/10.1073/pnas.240309797

7. Shi, S., & Gronthos, S. (2003). Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. Journal of Bone and Mineral Research, 18(4), 696–704. https://doi.org/10.1359/jbmr.2003.18.4.696

8. Pihlstrom, B. L., Michalowicz, B. S., & Johnson, N. W. (2005). Periodontal diseases. The Lancet, 366(9499), 1809–1820. https://doi.org/10.1016/S0140-6736(05)67728-8

9. Kinane, D. F., Stathopoulou, P. G., & Papapanou, P. N. (2017). Periodontal diseases. Nature Reviews Disease Primers, 3, 17038. https://doi.org/10.1038/nrdp.2017.38

10. Chen, F.-M., Sun, H.-H., Lu, H., & Yu, Q. (2012). Stem cell-delivery therapeutics for periodontal tissue regeneration. Biomaterials, 33(27), 6320–6344. https://doi.org/10.1016/j.biomaterials.2012.05.048

11. Yamada, Y., Nakamura, S., Ito, K., Sugito, T., Yoshimi, R., Nagasaka, T., & Baba, S. (2010). A feasibility of useful cell-based therapy by bone regeneration with deciduous tooth stem cells, dental pulp stem cells, or bone marrow-derived mesenchymal stem cells for clinical study using tissue engineering. Tissue Engineering Part A, 16(4), 1251–1260. https://doi.org/10.1089/ten.tea.2009.0732

12. Feinberg, A. P. (2018). The key role of epigenetics in human disease prevention and mitigation. New England Journal of Medicine, 378(14), 1323–1334. https://doi.org/10.1056/NEJMra1402513

13. Jones, P. A., Issa, J.-P. J., & Baylin, S. (2016). Targeting the cancer epigenome for therapy. Nature Reviews Genetics, 17(10), 630–641. https://doi.org/10.1038/nrg.2016.93

14. Seo, B. M., Miura, M., Gronthos, S., Bartold, P. M., Batouli, S., Brahim, J., Young, M., Robey, P. G., Wang, C. Y., & Shi, S. (2004). Investigation of multipotent postnatal stem cells from human periodontal ligament. The Lancet, 364(9429), 149–155. https://doi.org/10.1016/S0140-6736(04)16627-0

15. Wang, Xiping, et al. "NUP62 alleviates senescence and promotes the stemness of human dental pulp stem cells via NSD2-dependent epigenetic reprogramming." International Journal of Oral Science 17.1 (2025): 34.

16. Ivanovski, S., Gronthos, S., Shi, S., & Bartold, P. M. (2006). Stem cells in the periodontal ligament. Oral Diseases, 12(4), 358–363. https://doi.org/10.1111/j.1601-0825.2006.01276.x

17. Caplan, A. I., & Correa, D. (2011). The MSC: An injury drugstore. Cell Stem Cell, 9(1), 11–15. https://doi.org/10.1016/j.stem.2011.06.008

18. Rudin, C. (2019). Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nature Machine Intelligence, 1(5), 206–215. https://doi.org/10.1038/s42256-019-0048-x

19. Ghassemi, M., Oakden-Rayner, L., & Beam, A. L. (2021). The false hope of current approaches to explainable artificial intelligence in health care. The Lancet Digital Health, 3(11), e745–e750. https://doi.org/10.1016/S2589-7500(21)00208-9

20. Price, W. N., & Cohen, I. G. (2019). Privacy in the age of medical big data. Nature Medicine, 25(1), 37–43. https://doi.org/10.1038/s41591-018-0272-7

21. Mittelstadt, B. (2019). Principles alone cannot guarantee ethical AI. Nature Machine Intelligence, 1(11), 501–507. https://doi.org/10.1038/s42256-019-0114-4

22. Vayena, E., Blasimme, A., & Cohen, I. G. (2018). Machine learning in medicine: Addressing ethical challenges. PLoS Medicine, 15(11), e1002689. https://doi.org/10.1371/journal.pmed.1002689

Downloads

Published

2026-10-14

How to Cite

Joline Lof, Iain Whittaker, & Mirthe van Emmelen. (2026). Integrating Machine Learning and Epigenetic Biomarkers to Evaluate Dental Pulp Stem Cell-Based Therapies for Periodontal Tissue Regeneration. International Journal of Clinical and Translational Medicine, 1(1). Retrieved from https://www.ijctmed.org/index.php/home/article/view/230